Home - Products - Others - Other Targets - 1-(4-Carbethoxyphenyl)-piperazin

1-(4-Carbethoxyphenyl)-piperazin

CAS No. 80518-57-6

1-(4-Carbethoxyphenyl)-piperazin( —— )

Catalog No. M28685 CAS No. 80518-57-6

1-(4-Carbethoxyphenyl)-piperazin is a chemical compound.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 45 In Stock
10MG 68 In Stock
25MG 115 In Stock
50MG 173 In Stock
100MG 258 In Stock
200MG 388 In Stock
500MG 642 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    1-(4-Carbethoxyphenyl)-piperazin
  • Note
    Research use only, not for human use.
  • Brief Description
    1-(4-Carbethoxyphenyl)-piperazin is a chemical compound.
  • Description
    1-(4-Carbethoxyphenyl)-piperazin is a chemical compound.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    80518-57-6
  • Formula Weight
    234.299
  • Molecular Formula
    C13H18N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCOC(=O)c1ccc(cc1)N1CCNCC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Vedpal, et al. A new pyrimidine alkaloid from the roots of Tadehagi triquetrum (L.) H.Ohashi. Nat Prod Res. 2021 Feb;35(3):413-420.
molnova catalog
related products
  • 1,3,6-Trihydroxy-2-m...

    1,3,6-Trihydroxy-2-methylanthraquinone 3-O-alpha-L-rhamnosyl-(1->2)-beta-D-glucoside is a natural product.

  • 5,7,3-Trihydroxy-6,4...

    5,7,3'-Trihydroxy-6,4',5'-trimethoxyflavone is a natural product from Artemisia argyi.

  • Luxdegalutamide

    Luxdegalutamide (ARV-766) is a novel, potent, and orally bioavailable proteolytic targeting chimera (PROTAC) protein degrader that degrades not only wild-type AR but also clinically relevant AR LBD mutants, including the most prevalent AR L702H, H875Y, and T878A mutations.